Oral minocycline for the treatment of retinitis pigmentosa–associated cystoid macular edema: results of a phase I/II clinical trial

Hartong DT, Berson EL, Dryja TP (2006) Retinitis pigmentosa. Lancet 368:1795–1809. https://doi.org/10.1016/S0140-6736(06)69740-7

Article  CAS  PubMed  Google Scholar 

Daiger SP, Sullivan LS, Bowne SJ (2013) Genes and mutations causing retinitis pigmentosa. Clin Genet 84:132–141. https://doi.org/10.1111/cge.12203

Article  CAS  PubMed  Google Scholar 

Adackapara CA, Sunness JS, Dibernardo CW, Melia BM, Dagnelie G (2008) Prevalence of cystoid macular edema and stability in oct retinal thickness in eyes with retinitis pigmentosa during a 48-week lutein trial. Retina 28:103–110. https://doi.org/10.1097/IAE.0b013e31809862aa

Article  PubMed  Google Scholar 

Hajali M, Fishman GA (2009) The prevalence of cystoid macular oedema on optical coherence tomography in retinitis pigmentosa patients without cystic changes on fundus examination. Eye (Lond) 23:915–919. https://doi.org/10.1038/eye.2008.110

Article  CAS  PubMed  Google Scholar 

Hajali M, Fishman GA, Anderson RJ (2008) The prevalence of cystoid macular oedema in retinitis pigmentosa patients determined by optical coherence tomography. Br J Ophthalmol 92:1065–1068. https://doi.org/10.1136/bjo.2008.138560

Article  CAS  PubMed  Google Scholar 

Testa F, Rossi S, Colucci R, Gallo B, Di Iorio V, della Corte M, Azzolini C, Melillo P, Simonelli F (2014) Macular abnormalities in Italian patients with retinitis pigmentosa. Br J Ophthalmol 98:946–950. https://doi.org/10.1136/bjophthalmol-2013-304082

Article  PubMed  Google Scholar 

Karasu B (2020) Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors. Int Ophthalmol 40:677–687. https://doi.org/10.1007/s10792-019-01228-z

Article  PubMed  Google Scholar 

Blank T, Goldmann T, Koch M, Amann L, Schon C, Bonin M, Pang S, Prinz M, Burnet M, Wagner JE, Biel M, Michalakis S (2017) Early microglia activation precedes photoreceptor degeneration in a mouse model of CNGB1-linked retinitis pigmentosa. Front Immunol 8:1930. https://doi.org/10.3389/fimmu.2017.01930

Article  CAS  PubMed  Google Scholar 

Zhao L, Zabel MK, Wang X, Ma W, Shah P, Fariss RN, Qian H, Parkhurst CN, Gan WB, Wong WT (2015) Microglial phagocytosis of living photoreceptors contributes to inherited retinal degeneration. EMBO Mol Med 7:1179–1197. https://doi.org/10.15252/emmm.201505298

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peng B, Xiao J, Wang K, So KF, Tipoe GL, Lin B (2014) Suppression of microglial activation is neuroprotective in a mouse model of human retinitis pigmentosa. J Neurosci 34:8139–8150. https://doi.org/10.1523/JNEUROSCI.5200-13.2014

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cukras CA, Petrou P, Chew EY, Meyerle CB, Wong WT (2012) Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I/II clinical study. Invest Ophthalmol Vis Sci 53:3865–3874. https://doi.org/10.1167/iovs.11-9413

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chung YR, Kim YH, Lee SY, Byeon HE, Lee K (2019) Insights into the pathogenesis of cystoid macular edema: leukostasis and related cytokines. Int J Ophthalmol 12:1202–1208. https://doi.org/10.18240/ijo.2019.07.23

Article  PubMed  PubMed Central  Google Scholar 

Yoshida N, Ikeda Y, Notomi S, Ishikawa K, Murakami Y, Hisatomi T, Enaida H, Ishibashi T (2013) Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology 120:e5-12. https://doi.org/10.1016/j.ophtha.2012.07.008

Article  PubMed  Google Scholar 

Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95:15769–15774. https://doi.org/10.1073/pnas.95.26.15769

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 96:13496–13500. https://doi.org/10.1073/pnas.96.23.13496

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, Levison SW (2005) Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54:1559–1565. https://doi.org/10.2337/diabetes.54.5.1559

Article  CAS  PubMed  Google Scholar 

Genead MA, Fishman GA (2010) Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome. Arch Ophthalmol 128:1146–1150. https://doi.org/10.1001/archophthalmol.2010.172

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fishman GA, Apushkin MA (2007) Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa. Br J Ophthalmol 91:743–745. https://doi.org/10.1136/bjo.2006.107466

Article  PubMed  PubMed Central  Google Scholar 

Fishman GA, Gilbert LD, Anderson RJ, Marmor MF, Weleber RG, Viana MA (1994) Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa. Ophthalmology 101:687–693. https://doi.org/10.1016/s0161-6420(94)31277-2

Article  CAS  PubMed  Google Scholar 

Fishman GA, Gilbert LD, Fiscella RG, Kimura AE, Jampol LM (1989) Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol 107:1445–1452. https://doi.org/10.1001/archopht.1989.01070020519031

Article  CAS  PubMed  Google Scholar 

Fishman GA, Glenn AM, Gilbert LD (1993) Rebound of macular edema with continued use of methazolamide in patients with retinitis pigmentosa. Arch Ophthalmol 111:1640–1646. https://doi.org/10.1001/archopht.1993.01090120062023

Article  CAS  PubMed  Google Scholar 

Asahi MG, BobarnacDogaru GL, Onishi SM, Gallemore RP (2015) Strong topical steroid, NSAID, and carbonic anhydrase inhibitor cocktail for treatment of cystoid macular edema. Int Med Case Rep J 8:305–312. https://doi.org/10.2147/IMCRJ.S92794

Article  PubMed  PubMed Central  Google Scholar 

Ikeda Y, Hisatomi T, Yoshida N, Notomi S, Murakami Y, Enaida H, Ishibashi T (2012) The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol 250:809–814. https://doi.org/10.1007/s00417-011-1904-5

Article  CAS  PubMed  Google Scholar 

Liew G, Moore AT, Webster AR, Michaelides M (2015) Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa. Invest Ophthalmol Vis Sci 56:1531–1536. https://doi.org/10.1167/iovs.14-15995

Article  CAS  PubMed  Google Scholar 

Yeo JH, Min CH, Yoon YH (2022) Effect of oral carbonic anhydrase inhibitor on cystoid macular edema associated with retinitis pigmentosa: an OCT and OCT angiography study. Retina 42:1796–1804. https://doi.org/10.1097/IAE.0000000000003531

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shimokawa S, Murakami Y, Fujiwara K, Funatsu J, Nakatake S, Koyanagi Y, Akiyama M, Yoshida N, Takeda A, Ikeda Y, Sonoda KH (2022) Recurrence rate of cystoid macular edema with topical dorzolamide treatment and its risk factors in retinitis pigmentosa. Retina 42:168–173. https://doi.org/10.1097/IAE.0000000000003286

Article  CAS  PubMed  Google Scholar 

Kitahata S, Hirami Y, Takagi S, Kime C, Fujihara M, Kurimoto Y, Takahashi M (2018) Efficacy of additional topical betamethasone in persistent cystoid macular oedema after carbonic anhydrase inhibitor treatments in retinitis pigmentosa. BMJ Open Ophthalmol 3:e000107. https://doi.org/10.1136/bmjophth-2017-000107

Article  PubMed  PubMed Central  Google Scholar 

Park UC, Park JH, Ma DJ, Cho IH, Oh BL, Yu HG (2020) A randomized paired-eye trial of intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa. Retina 40:1359–1366. https://doi.org/10.1097/IAE.0000000000002589

Article  PubMed  Google Scholar 

Veritti D, Sarao V, De Nadai K, Chizzolini M, Parmeggiani F, Perissin L, Lanzetta P (2020) Dexamethasone implant produces better outcomes than oral acetazolamide in patients with cystoid macular edema secondary to retinitis pigmentosa. J Ocul Pharmacol Ther 36:190–197. https://doi.org/10.1089/jop.2018.0153

Article  CAS  PubMed  Google Scholar 

Strong SA, Peto T, Bunce C, Xing W, Georgiou M, Esposti SD, Kalitzeos A, Webster A, Michaelides M (2020) Prospective exploratory study to assess the safety and efficacy of aflibercept in cystoid macular oedema associated with retinitis pigmentosa. Br J Ophthalmol 104:1203–1208. https://doi.org/10.1136/bjophthalmol-2019-315152

Article  PubMed  Google Scholar 

Shah CR, Brent MH (2010) Treatment of retinitis pigmentosa-related cystoid macular edema with intravitreous ranibizumab. Retin Cases Brief Rep 4:291–293. https://doi.org/10.1097/ICB.0b013e3181af7b6c

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif